Report Detail

Medical Devices DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review

  • RnM3517457
  • |
  • 11 June, 2019
  • |
  • Global
  • |
  • 56 Pages
  • |
  • GlobalData
  • |
  • Medical Devices

Table of Contents

    Table of Contents

      List of Tables

        List of Figures

          Section 1 - About the Company

            DURECT Corp - Key Facts

              DURECT Corp - Key Employees

                DURECT Corp - Key Employee Biographies

                  DURECT Corp - Major Products and Services

                    DURECT Corp - History

                      DURECT Corp - Company Statement

                        DURECT Corp - Locations And Subsidiaries

                          Head Office

                            Section 2 – Company Analysis

                              Company Overview

                                DURECT Corp - Business Description

                                  Geographical Segment: Europe

                                    Performance

                                      Geographical Segment: Japan

                                        Performance

                                          Geographical Segment: Other

                                            Performance

                                              Geographical Segment: United States

                                                Performance

                                                  DURECT Corp - Corporate Strategy

                                                    DURECT Corp - SWOT Analysis

                                                      SWOT Analysis - Overview

                                                        DURECT Corp - Strengths

                                                          DURECT Corp - Weaknesses

                                                            DURECT Corp - Opportunities

                                                              DURECT Corp - Threats

                                                                DURECT Corp - Key Competitors

                                                                  Section 3 – Company Financial Ratios

                                                                    Financial Ratios - Capital Market Ratios

                                                                      Financial Ratios - Annual Ratios

                                                                        Performance Chart

                                                                          Financial Performance

                                                                            Financial Ratios - Interim Ratios

                                                                              Financial Ratios - Ratio Charts

                                                                                Section 4 – Company’s Lifesciences Financial Deals and Alliances

                                                                                  DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

                                                                                    DURECT Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

                                                                                      DURECT Corp, Recent Deals Summary

                                                                                        Section 5 – Company’s Recent Developments

                                                                                          May 07, 2019: DURECT announces first quarter 2019 financial results and update of programs

                                                                                            Apr 25, 2019: DURECT appoints two new board members

                                                                                              Mar 07, 2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs

                                                                                                Dec 17, 2018: DURECT announces retirement of Dr. Felix Theeuwes as chairman of the board and distinguished scientist

                                                                                                  Oct 01, 2018: DURECT names Michael H. Arenberg as Chief Financial Officer

                                                                                                    Oct 01, 2018: DURECT names Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer

                                                                                                      Sep 30, 2018: DURECT announces third quarter 2018 financial results and provides corporate update

                                                                                                        Aug 01, 2018: DURECT announces second quarter 2018 financial results and provides corporate update

                                                                                                          May 02, 2018: DURECT Reports First Quarter 2018 Financial Results

                                                                                                            Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs

                                                                                                              Section 6 – Appendix

                                                                                                                Methodology

                                                                                                                  Ratio Definitions

                                                                                                                    About GlobalData

                                                                                                                      Contact Us

                                                                                                                        Disclaimer

                                                                                                                        DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

                                                                                                                        The profile contains critical company information including:

                                                                                                                        - Business description – A detailed description of the company’s operations and business divisions.
                                                                                                                        - Corporate strategy – Analyst’s summarization of the company’s business strategy.
                                                                                                                        - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
                                                                                                                        - Company history – Progression of key events associated with the company.
                                                                                                                        - Major products and services – A list of major products, services and brands of the company.
                                                                                                                        - Key competitors – A list of key competitors to the company.
                                                                                                                        - Key employees – A list of the key executives of the company.
                                                                                                                        - Executive biographies – A brief summary of the executives’ employment history.
                                                                                                                        - Key operational heads – A list of personnel heading key departments/functions.
                                                                                                                        - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
                                                                                                                        - Key manufacturing facilities – A list of key manufacturing facilities of the company.
                                                                                                                        - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
                                                                                                                        - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

                                                                                                                        Highlights

                                                                                                                        DURECT Corp (Durect) is a specialty pharmaceutical company. It develops pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. The company’s major products include Alzet, an osmotic pump; and Lactel, a biodegradable polymer. The company’s product pipeline comprises DUR-928 indicated for treatment of acute organ injuries and metabolic/lipid disorders; Posimir, indicated for post-operative pain; Oradur, indicated for chronic pain and attention deficit hyperactivity disorder; and sustained-release ophthalmology product. Durect’s major drug delivery technology platforms include Saber, Cloud and Oradur. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in Cupertino, California, the US.

                                                                                                                        DURECT Corp Key Recent Developments

                                                                                                                        May 07,2019: DURECT announces first quarter 2019 financial results and update of programs
                                                                                                                        Apr 25,2019: DURECT appoints two new board members
                                                                                                                        Mar 07,2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs
                                                                                                                        Dec 17,2018: DURECT announces retirement of Dr. Felix Theeuwes as chairman of the board and distinguished scientist
                                                                                                                        Oct 01,2018: DURECT names Michael H. Arenberg as Chief Financial Officer

                                                                                                                        Key benefits of buying this profile include:

                                                                                                                        You get detailed information about the company and its operations to identify potential customers and suppliers.
                                                                                                                        - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

                                                                                                                        Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
                                                                                                                        - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

                                                                                                                        Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
                                                                                                                        - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

                                                                                                                        Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
                                                                                                                        - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

                                                                                                                        Gain key insights into the company for academic or business research.
                                                                                                                        - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

                                                                                                                        Note: Some sections may be missing if data is unavailable for the company


                                                                                                                        Summary:
                                                                                                                        Get latest Market Research Reports on DURECT Corp (DRRX). Industry analysis & Market Report on DURECT Corp (DRRX) is a syndicated market report, published as DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review. It is complete Research Study and Industry Analysis of DURECT Corp (DRRX) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                        REPORT YOU MIGHT BE INTERESTED

                                                                                                                        Purchase this Report

                                                                                                                        $500.00
                                                                                                                        $1,000.00
                                                                                                                        $1,500.00
                                                                                                                        389.16
                                                                                                                        778.31
                                                                                                                        1,167.47
                                                                                                                        453.57
                                                                                                                        907.14
                                                                                                                        1,360.72
                                                                                                                        54,550.50
                                                                                                                        109,101.00
                                                                                                                        163,651.50
                                                                                                                        35,817.05
                                                                                                                        71,634.10
                                                                                                                        107,451.15
                                                                                                                        Credit card Logo

                                                                                                                        Related Reports


                                                                                                                        Reason to Buy

                                                                                                                        Request for Sample of this report